RNAZ Gains Attention as TransCode and Quantum Leap Plan Phase 2a Colorectal Cancer Trial with TTX-MC138
Market Chameleon (Thu, 5-Feb 9:53 AM)
TransCode and Quantum Leap Target Minimal Residual Disease with New Phase 2a Trial for Colorectal Cancer
Market Chameleon (Thu, 5-Feb 8:34 AM)
